NHS National Framework Agreement for the supply of aseptically prepared cytotoxic medicines and monoclonal antibodies — North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the authority’s discretion) for a period or periods ...